Amnesia and Memory Loss
Updated: 02/20/2006
References
Ackerman PT, Dykman RA, et al. A trial of piracetam in two subgroups of students with dyslexia enrolled in summer tutoring. J Learn Disabil. 1991 Nov;24(9):542-9.
Amenta F, Parnetti L, et al. Treatment of cognitive dysfunction associated with Alzheimer’s disease with cholinergic precursors: Ineffective treatments or inappropriate approaches? Mech Ageing Dev. 2001 Nov;122(16):2025–40.
Andallu B, Radhika B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J Exp Biol. 2000 Jun;38(6):607–9.
Benton D, Fordy J, et al. The impact of long-term vitamin supplementation on cognitive functioning. Psychopharmacol.1995:117;298–305.
Bhattacharya SK, Bhattacharya A, et al. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: An experimental study. Phytomedicine. 2000 Dec;7(6):463–9.
Brna TG Jr, Wilson CC. Psychogenic amnesia. Am Family Phys.1990 Jan;4(1):229–34.
Buresova O, Bures J. Piracetam-induced facilitation of interhemispheric transfer of visual information in rats. Psychopharmacologia. 1976;46(1):93–102.
Carmel R. Megoblastic anemias. Curr Opin Hematol.1994;1(2):107–12.
Chaudhary G, Sharma U, et al. Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol. 2003 May;30(5–6):399–404.
Cheng DH, Ren H, et al. Huperzine A, a novel promising acetylcholinesterase inhibitor. Neuroreport.1996;8:97–101.
Chiu PJ, Tetzloff G, et al. Comparative effects of vinpocetine and 8-Br cyclic GMP on the contraction and Ca fluxes in the rabbit aorta. Am J Hypertens.1988 Jul;1(3 Pt.1):262–8.
Choudhary MI, Yousuf S, et al. Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull (Tokyo). 2004 Nov;52(11):1358–61.
Croisile B, Trillet M, et al. Long-term and high dose piracetam treatment of AD. Neurology.1993 Feb;43(2):301–5.
Crook TH, Tinklenberg J, et al. Effects of phosphatidylserine in age-associated memory impairment. Neurology. 1991 May;41(5):644–9.
De Hoz L, Martin SJ, et al. Neural basis of memory loss. Plos Biol. 2004;2(8):e225.
Delwaide PJ, Gyselynck-Mambourg AM, et al. Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurol Scand. 1986 Feb;73(2):136–40.
Dhuley JN. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother Res. 2001 Sep;15(6):524–8.
Flicker L, Grimely Evans G. Piracetam for dementia or cognitive impairment. Cochrane Database Syst Rev. 2001;(2):CD001011.
Funfgeld EW, Baggen M, et al. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer’s type (SDAT). Prog Clin Biol Res. 1989;317:1235–46.
Goncharova ND, Lapin BA. Effects of aging on hypothalamic-pituitary-adrenal system function in non-human primates. Mech Ageing Dev. 2002 Apr 30;123(8):1191–201.
Grodstein F, Chen J, et al. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr. 2003 Apr;77:975–84.
Gulyas B, Halldin C, et al. Brain uptake and plasma metabolism of [11C] vinpocetine: A preliminary PET study in a cynomolgus monkey. J Neuroimaging. 1999 Oct;9(4):217–22.
Halliwell B, Gutteridge JMC. Oxygen radicals in the nervous system. Trends Neurosci. 1985;8:22–6.
Hara H, Kato H, et al. Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus. Brain Res.1990;510:335–8.
Hutto BR. Folate and cobalamin in psychiatric illness. Compr Psychiatry. 1997;38(6):305–14.
Karishma KK, Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci. 2002 Aug;16(3):445–53.
Kasper DL, Braunwald DE, et al. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Professional; 2005.
Kleijnen J, Knipschild P. Gingko biloba for cerebral insufficiency. Br J Clin Pharmacol. 1992 Oct 16;14(5):316–20.
Koistinaho M, Koistinaho J. Interactions between Alzheimer’s disease and cerebral ischemia: Focus on inflammation. Brain Res Brain Res Rev. 2005 Apr;48(2):240–50.
Kuboyama T, Tohda C, et al. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol. 2005 Apr;144(7):961–71.
Li MH, Jang JH, et al. Protective effects of oligomers of grape seed polyphenols against beta-amyloid-induced oxidative cell death. Ann NY Acad Sci. 2004 Dec;1030:317–29.
Liang YQ, Tang XC. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats. Neurosci Lett. 2004 May 6;361(1–3):56–9.
Mathis C, Meziane H, et al. Models for the study of memory and neurosteroids. J Soc Biol. 1999;193(3):299–306.
Meador K, Loring D, et al. Preliminary findings of high dose thiamine in dementia of Alzheimer’s type. J Geriatr Psychiatry Neurol.1993a;6:222–9.
Meador K, Nichols ME, et al. Evidence for a central cholingeric effect of high dose thiamine. Ann Neurol.1993b;34:724–6.
Meieran SE, Reus VI, et al. Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation. Psychoneuroendocrinology. 2004 May;29(4):486–500.
Mishra LC, Singh BB, et al. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review. Altern Med Rev. 2000 Aug;5(4):334–46.
Miyamoto M, Murphy TH, et al. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther. 1989 Sep;250(3):1132–40.
Mohan R, Hammers HJ, et al. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis. 2004;7(2):115–22.
Molnar P, Gaal L, et al. The impairment of long-term potentiation in rats with medial septal lesion and its restoration by cognition enhancers. Neurobiology. 1994;2(3):255–66.
Nagy Z, Vargha P, et al. Meta-analysis of Cavinton. Praxis.1998;7:63–8.
Owais M, Sharad KS, et al. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine. 2005 Mar;12(3):229–35.
Padmavathi B, Rath PC, et al. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. Evid Based Complement Alternat Med. 2005 Mar;2(1):99–105.
Parnetti L, Amenta F, et al. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: An analysis of published clinical data. Mech Ageing Dev. 2001 Nov;122(16):2041–55.
Pilch H, Muller WE. Chronic treatment with piracetam elevates muscarinic cholinergic receptor density in frontal cortex of aged mice. Pharmacopsychiatry.1998 Nov;21(6):324–5.
Prakash J, Gupta SK, et al. Withania somnifera root extract prevents DMBA-induced squamous cell carcinoma of skin in Swiss albino mice. Nutr Cancer. 2002;42(1):91–7.
Racchi M, Govoni S, et al. DHEA and the relationship with aging and memory: A possible link with protein kinase C functional machinery. Brain Res Brain Res Rev. 2001 Nov;37(1–3):287–93.
Rogers SL, Farlow MR, et al. A 24-week double-blind placebo-controlled trial of donepezil in patients with AD. Neurology.1998 Jan;50(1):136–45.
Schreiber S, Kampf-Sherf O, et al. An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. Isr J Psychiatry Relat Sci. 2000;37(4):302–7.
Smidt LJ, Cremin FM, et al. Influence of thiamin supplementation on the health and general well-being of an elderly Irish population with marginal thiamin deficiency. J Gerontol.1991;46(1):M16–M22.
Stole S. Indole derivatives as neuroprotectants. Life Sci.1999;1943–50.
Subhan Z, Hindmarch I. Psychopharmacological effects of vinpocetine in normal healthy volunteers. Eur J Clin Pharmacol.1985;28(5):567–71.
Szatmari SZ, Whitehouse PJ. Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev. 2003;(1):CD003119.
Tan RS, Pu SJ. The andropause and memory loss: Is there a link between androgen decline and dementia in the aging male? Asian J Androl. 2001;3(3):169–74.
Taylor PJ, Kopelman MD. Amnesia for criminal offenses. Psychol Med.1984 Aug;14(3):581–8.
Winblad B. Piracetam: A review of pharmacological properties and clinical uses. CNS Drug Rev. 2005 Summer;11(2):169–82.
Xu SS, Gao ZX. Efficacy of tablet huperzine A on memory, cognition and behavior in Alzheimer’s disease. Chung Kuo Yao Li Hsueh Pao.1995;16(5):391–5.
Zhang Z, Wang X, et al. Clinical efficacy and safety of huperzine alpha in treatment of mild to moderate Alzheimer disease—a placebo controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14);941–4.
Zietz B, Hrach S, et al. Differential age-related changes of hypothalamus-pituitary-adrenal axis hormones in healthy women and men: Role of interleukin 6. Exp Clin Endocrinol Diabetes. 2001;109(2):93–101.